CTech's Monday Roundup of Israeli Tech News
Teva’s Copaxone successors are still far from success; Former Israeli prime minister turned cannabis entrepreneur Ehud Barak believes that Israel’s cannabis potential is immense
14:3306.05.19
Analysis | Teva’s Copaxone successors are still far from success. Teva’s first quarter report for 2019, published Thursday, shows that while the drugmaker is progressing with its financial rehabilitation program, its net debt to EBITDA ratio is leaving the company in dangerous waters. Read more
Teva CEO Kåre Schultz. Photo: Sivan Farage
Former Israeli prime minister turned cannabis entrepreneur Ehud Barak believes that Israel’s cannabis potential is immense. Barak, who chairs cannabis company InterCure, spoke Monday at Calcalist’s cannabis conference. Read more
Israel bombed Hamas building to thwart cyber attack. A ceasefire between Israel and Hamas was announced early Monday morning, bringing an end to 48 hours of fighting that saw 23 Palestinians and four Israeli civilians dead. Read more
Israel doubles down on Beresheet 2.0. Beresheet crashed on its April moon landing, still making it the first privately funded spacecraft to reach lunar orbit. Read more
A week and a half from the final, Israel’s Eurovision is floundering. On Sunday, organizers decided to cancel VIP ticket sales for the semifinals and began offering a 10% discount on tickets. Read more
Heart monitoring company CardiadSense raises $3.5 million. CardiacSense develops a watch-like device that tracks factors like arrhythmia, heart rate, oxygen saturation and blood pressure in users for early detection of stroke or cardiac arrest. Read more
The American Diabetes Association partners with diabetes monitoring company Dario. Israel-headquartered Dario develops a diabetes monitoring device that lets users test and track their blood-glucose levels in real time using a smartphone. Read more
